Heart International最新文献

筛选
英文 中文
ST-elevation Myocardial Infarction and Multivessel Coronary Artery Disease - A Critical Review of Current Practice, Evidence and Meta-analyses. st段抬高型心肌梗死和多支冠状动脉疾病——当前实践、证据和荟萃分析的重要回顾
IF 0.2
Heart International Pub Date : 2020-12-23 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.80
Filippo Figini, Shao Liang Chen, Imad Sheiban
{"title":"ST-elevation Myocardial Infarction and Multivessel Coronary Artery Disease - A Critical Review of Current Practice, Evidence and Meta-analyses.","authors":"Filippo Figini,&nbsp;Shao Liang Chen,&nbsp;Imad Sheiban","doi":"10.17925/HI.2020.14.2.80","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.80","url":null,"abstract":"<p><p>In recent years, practice and guidelines for patients with ST-elevation myocardial infarction (STEMI) have evolved from a 'culprit-only approach' to complete revascularisation; however, several issues remain, particularly regarding assessment of non-culprit lesions and timing of their revascularisation. Complete revascularisation should be performed in patients presenting with STEMI; however, available studies often present contradictory results regarding the optimal timing of non-culprit lesion percutaneous coronary intervention (PCI). The aim of this review is to provide a practical approach for the assessment of patients presenting with STEMI and multivessel coronary artery disease by analysing randomised trials, meta-analyses and our clinical experience. We recommend multivessel revascularisation at the time of primary PCI for simple cases, while we suggest deferring treatment of complex lesions; the optimal timing of staged PCI should be individualised according to clinical judgement.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"80-85"},"PeriodicalIF":0.2,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562769/pdf/heart-int-14-80.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computed Tomography-based Patient-specific Biomechanical and Fluid Dynamic Study of Anomalous Coronary Arteries with Origin from the Opposite Sinus and Intramural Course. 基于计算机断层扫描的对侧窦及壁内异常冠状动脉的患者特异性生物力学和流体动力学研究。
IF 0.2
Heart International Pub Date : 2020-12-23 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.105
Gianluca Rigatelli, Marco Zuin
{"title":"Computed Tomography-based Patient-specific Biomechanical and Fluid Dynamic Study of Anomalous Coronary Arteries with Origin from the Opposite Sinus and Intramural Course.","authors":"Gianluca Rigatelli,&nbsp;Marco Zuin","doi":"10.17925/HI.2020.14.2.105","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.105","url":null,"abstract":"<p><strong>Background: </strong>The anomalous coronary arteries originating from the opposite sinus of Valsalva (ACAOS) constitutes one of the most clinically relevant coronary artery anomalies in adults. Exact pathophysiology and the impact of intramural (IM) course segment stenting in ACAOS with IM course (ACAOS-IM) has not been clarified. We aimed to elucidate the pathophysiology and impact of stenting applying biomechanical and computational fluid dynamics to computed tomography (CT) in patient-specific coronary vessel reconstruction.</p><p><strong>Methods: </strong>We separated coronary artery (left or L-, right or R-) ACAOS-IM into segments (proximal, mid and distal), based on coronary angiography and coronary CT angiography features, in a series of patients at Rovigo General Hospital, Italy, between 1 January 2003 and 1 January 2018. Blood pressure gradient across the coronary circulation, calculated blood flow, vorticity magnitude, wall shear stress (WSS) and IM segment deformation were analysed by simulating exercise, before and after virtual stent implantation.</p><p><strong>Results: </strong>In 21 symptomatic patients (13 males, mean age 46.1 ± 8.1 years, L-ACAOS-IM in 9 and R-ACAOS-IM in 12 patients), computational fluid dynamic analysis in both L- and R-ACAOS demonstrated higher basal WSS values in the IM course (9.5 ± 0.2 and 8.6 ± 0.2 Pa for R- and L-ACAOS, respectively), than in the rest of the vessels. These values decreased after stenting. Vorticity magnitude significantly decreased after stenting as well, compared with baseline. Biomechanical deformation analysis revealed not only compression, but also a twisting of the IM segment with a mean distal pressure drop of 32% and 35% in R- and L-ACAOS, respectively, which was corrected by stent implantation.</p><p><strong>Conclusions: </strong>In both L- and R-ACAOS subtypes, the IM segment appeared to be phasically compressed and deformed with a degree of twisting that causes resting and exercise cross-sectional deformation and a drop in distal pressure. Stenting of the IM segment results in normalisation of the flow profile, correction of the IM segment deformation and reverses the drop in pressure, for both variants of ACAOS.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"105-111"},"PeriodicalIF":0.2,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524708/pdf/heart-int-14-105.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40676051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Spontaneously Recanalised Coronary Thrombus in the Left Anterior Descending Artery Presenting as Ventricular Tachycardia. 左前降支自发再通冠状动脉血栓表现为室性心动过速。
IF 0.2
Heart International Pub Date : 2020-12-22 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.123
Jie Man Low, Noah Kimit, Rizwan Rashid, Magdi El-Omar
{"title":"Spontaneously Recanalised Coronary Thrombus in the Left Anterior Descending Artery Presenting as Ventricular Tachycardia.","authors":"Jie Man Low,&nbsp;Noah Kimit,&nbsp;Rizwan Rashid,&nbsp;Magdi El-Omar","doi":"10.17925/HI.2020.14.2.123","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.123","url":null,"abstract":"<p><p>Spontaneously recanalized coronary thrombus (SRCT), also known as honeycomb, lotus root or Swiss-cheese lesion, is an increasingly recognised finding in patients undergoing coronary angiography. It is thought to arise from partial resorption of an initially occlusive thrombus. Most patients present with angina or exertional breathlessness. We describe a case of a 69-year-old patient who presented with ventricular tachycardia and was found to have SRCT in the left anterior descending artery on coronary angiography. Echocardiography and left ventricular (LV) angiography showed an akinetic, aneurysmal, thin-walled LV apex, diagnostic of an old anterior infarct. We highlight the role of optical coherence tomography in making the diagnosis and discuss the available management options of this condition.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"123-128"},"PeriodicalIF":0.2,"publicationDate":"2020-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524615/pdf/heart-int-14-123.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Coronary Computed Tomography for Calcium Screening of Atherosclerosis. 冠状动脉ct在动脉粥样硬化钙筛查中的应用。
IF 0.2
Heart International Pub Date : 2020-12-17 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.76
Joshua Beverly, Matthew J Budoff
{"title":"Use of Coronary Computed Tomography for Calcium Screening of Atherosclerosis.","authors":"Joshua Beverly,&nbsp;Matthew J Budoff","doi":"10.17925/HI.2020.14.2.76","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.76","url":null,"abstract":"<p><p>Coronary artery calcium (CAC) scoring serves as a highly specific marker of coronary atherosclerosis. Based on the results of multiple large-scale, longitudinal population-based studies, CAC scoring has emerged as a reliable predictor of atherosclerotic cardiovascular disease (ASCVD) presence and risk assessment in asymptomatic patients across all age, sex and racial groups. Therefore, the measurement of CAC is useful in guiding clinical decision-making for primary prevention (e.g. use of statin and aspirin). This tool has already been incorporated into the clinical guidelines and is steadily being integrated into standard clinical practice. The adoption of CAC scoring will be important for curbing the progressive burden that ASCVD is exerting on our healthcare system. It has already been projected that CAC testing will decrease healthcare spending and will hopefully be shown to improve ASCVD outcomes. The purpose of this review is to summarise the evidence regarding calcium screening for atherosclerosis, particularly in asymptomatic individuals, including the pathophysiology, the prognostic power of CAC in the context of population-based studies, the progressive inclusion of CAC into clinical guidelines and the existing concerns of cost and radiation.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"76-79"},"PeriodicalIF":0.2,"publicationDate":"2020-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562964/pdf/heart-int-14-76.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged Extracorporeal Membrane Oxygenation Support In a Patient with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome-associated Fulminant Myocarditis - A Case Report and Literature Review. 嗜酸性粒细胞增多和全身症状伴暴发性心肌炎的药物反应患者的长期体外膜氧支持- 1例报告及文献复习
IF 0.2
Heart International Pub Date : 2020-12-11 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.112
Chutima Seree-Aphinan, Nawaporn Assanangkornchai, Thanapon Nilmoje
{"title":"Prolonged Extracorporeal Membrane Oxygenation Support In a Patient with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome-associated Fulminant Myocarditis - A Case Report and Literature Review.","authors":"Chutima Seree-Aphinan,&nbsp;Nawaporn Assanangkornchai,&nbsp;Thanapon Nilmoje","doi":"10.17925/HI.2020.14.2.112","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.112","url":null,"abstract":"<p><p><b>Introduction</b>: Myocarditis is a rare presentation of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, traditionally associated with poor clinical outcomes. Prompt recognition and treatment are crucial. <b>Case presentation</b>: A 16-year-old patient presented with acute chest pain, hypotension, and pulmonary oedema 2 months after being diagnosed with trimethoprim/sulfamethoxazole-induced DRESS syndrome. Typical DRESS features were absent at onset of these symptoms. Echocardiography demonstrated biventricular systolic dysfunction, and electrocardiography (ECG) showed complete right bundle branch block and diffuse ST-segment elevation. The patient was admitted for high-dose inotropic support; however, his condition deteriorated. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and intra-aortic balloon pump were initiated on the third day of admission. Endomyocardial biopsy suggested the diagnosis of DRESS-associated myocarditis and a high-dose corticosteroid was commenced. While he was ECMO-dependent, the patient suffered multiple episodes of ventricular tachycardia on a background of cardioversion-resistant accelerated idioventricular rhythm. After 24 days of ECMO support, the ventricular function improved, and ECG reverted to sinus rhythm. His recovery allowed corticosteroid discontinuation 15 months after hospital discharge. <b>Conclusion</b>: Typical DRESS syndrome features may not accompany the onset of DRESS-associated myocarditis. Mechanical circulatory support and adequate immunosuppression could save patients with malignant arrhythmias and delayed myocardial recovery.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"112-117"},"PeriodicalIF":0.2,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524603/pdf/heart-int-14-112.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Transoesophageal Echocardiography in Surgical Removal of a Mediastinal Tumour. 经食管超声心动图在纵隔肿瘤手术切除中的作用。
IF 0.2
Heart International Pub Date : 2020-10-30 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.118
Ajay Kumar Jha
{"title":"The Role of Transoesophageal Echocardiography in Surgical Removal of a Mediastinal Tumour.","authors":"Ajay Kumar Jha","doi":"10.17925/HI.2020.14.2.118","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.118","url":null,"abstract":"<p><p>The complete and safe removal of a mediastinal mass requires cardiopulmonary bypass if the mass encroaches or compresses the heart and its great vessels. A 15-year-old male presented with a huge mediastinal mass with gradually worsening symptoms. Surgical removal of the tumour was planned under general anaesthesia and cardiopulmonary bypass based upon contrast-enhanced computed tomography of the chest, which suggested infiltration of the cardiac structures. Intraoperative transoesophageal echocardiography revealed a distinct separation of the tumour mass from the heart and its great vessels. The mass was excised <i>en bloc</i> without cardiopulmonary bypass.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"118-120"},"PeriodicalIF":0.2,"publicationDate":"2020-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524593/pdf/heart-int-14-118.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pulmonary Regurgitation - Results from the Harmony™ Transcatheter Pulmonary Valve Trial. 肺返流——Harmony™经导管肺动脉瓣试验结果
IF 0.2
Heart International Pub Date : 2020-10-20 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.2.67
John Cheatham
{"title":"Pulmonary Regurgitation - Results from the Harmony™ Transcatheter Pulmonary Valve Trial.","authors":"John Cheatham","doi":"10.17925/HI.2020.14.2.67","DOIUrl":"https://doi.org/10.17925/HI.2020.14.2.67","url":null,"abstract":"<p />","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 2","pages":"67-68"},"PeriodicalIF":0.2,"publicationDate":"2020-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524622/pdf/heart-int-14-67.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40565405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cardiovascular Effects of COVID-19 - What Do We Know and Where Should We Go? 新冠肺炎对心血管的影响-我们知道什么?我们应该去哪里?
IF 0.2
Heart International Pub Date : 2020-08-18 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.1.16
Matthew Ryan, Ozan Demir, Kevin O'Gallagher, Divaka Perera
{"title":"Cardiovascular Effects of COVID-19 - What Do We Know and Where Should We Go?","authors":"Matthew Ryan,&nbsp;Ozan Demir,&nbsp;Kevin O'Gallagher,&nbsp;Divaka Perera","doi":"10.17925/HI.2020.14.1.16","DOIUrl":"https://doi.org/10.17925/HI.2020.14.1.16","url":null,"abstract":"<p><p>Amongst the many challenges of the global pandemic, understanding the effects of coronavirus disease 2019 (COVID-19) on the cardiovascular system has emerged as a key priority. Emerging data indicate possible roles for cardiac biomarkers and cardiac imaging in the prognostic assessment of these patients, as well as implications of the vascular endothelium in the pathogenesis of the condition. From a therapeutic perspective, early data suggest that the provision of well-established treatments for cardiovascular disease, whether with angiotensin-converting enzyme inhibitors or primary angioplasty, is likely to be beneficial. These early data are of limited quality however, and robust studies are needed to address many of the key remaining questions.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 1","pages":"16-19"},"PeriodicalIF":0.2,"publicationDate":"2020-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524596/pdf/heart-int-14-16.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40567774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial? ISCHEMIA 试验后,血管重建术在稳定型冠状动脉疾病的治疗中还有用武之地吗?
IF 1.9
Heart International Pub Date : 2020-08-08 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.1.13
Andre Briosa E Gala, Nick Curzen
{"title":"Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial?","authors":"Andre Briosa E Gala, Nick Curzen","doi":"10.17925/HI.2020.14.1.13","DOIUrl":"10.17925/HI.2020.14.1.13","url":null,"abstract":"<p><p>The ISCHEMIA trial (International study of comparative health effectiveness with medical and invasive approaches; ClinicalTrials.gov Identifier: NCT01471522) has informed practice in patients with stable angina and confirms what other less definitive data have taught us, that in the absence of severe symptoms, significant left main disease or significant left ventricular dysfunction, there is no prognostic benefit of an early invasive/revascularisation strategy with optimal medical therapy (OMT) over OMT alone. Like all quality randomised trials, it has nuances: the invasive treatment group had much better relief of angina than the OMT alone group, and the rate of spontaneous myocardial infarction (MI) in follow-up was lower in the invasive group, although only after a prevalence of periprocedural MI. The clinical outcome consequence of the MI data, if indeed there is one, will only become clear at later follow-up. OMT is a powerful treatment, and reflex revascularisation in patients with little or no angina is not.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 1","pages":"13-15"},"PeriodicalIF":1.9,"publicationDate":"2020-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524617/pdf/heart-int-14-13.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40568877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Coronary Sinus Reducer - Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina. 冠状窦减速器-治疗难治性心绞痛的新工具的临床证据和新观点。
IF 0.2
Heart International Pub Date : 2020-08-04 eCollection Date: 2020-01-01 DOI: 10.17925/HI.2020.14.1.29
Carlo Zivelonghi, Stefan Verheye
{"title":"The Coronary Sinus Reducer - Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina.","authors":"Carlo Zivelonghi,&nbsp;Stefan Verheye","doi":"10.17925/HI.2020.14.1.29","DOIUrl":"https://doi.org/10.17925/HI.2020.14.1.29","url":null,"abstract":"<p><p>The coronary sinus reducer represents an emerging therapeutic option for patients suffering from chronic refractory angina. Current data indicate that the population suffering from angina symptoms despite maximal medical therapy and maximal achievable revascularisation - surgical or percutaneous - is constantly increasing. Also, the clinical outcome for these patients is strongly affected by the lack of adequate treatment, the occurrence of adverse events and the need for repeated hospitalisation. Growing evidence supports the clinical benefits of the coronary sinus reducer in relieving angina symptoms in this specific population, with emerging evidence of reduction in myocardial ischaemia following the implantation of the coronary sinus reducer. In this review, we provide an up-to-date description of the role of this relatively new device in the treatment of refractory angina, focusing not only on symptom relief but also on the increasing data that supports objective improvements in myocardial ischaemia.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"14 1","pages":"29-33"},"PeriodicalIF":0.2,"publicationDate":"2020-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524585/pdf/heart-int-14-29.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40567769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信